Nextgen Biomed Ltd (NXGN.TA)
ILA 64.1
(-0.77%)
ILA 64.1
(-0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.4 Million | -2.75 Million | -2.65 Million | -1.53 Million | -1.14 Million | -1.24 Million |
| Net Income | -14.2 Million | -8.58 Million | -2.55 Million | -1.29 Million | -1.21 Million | -1.27 Million |
| Depreciation & Amortization | 2000.00 | 7000.00 | 4000.00 | 1000.00 | - | 1000.00 |
| Deferred income taxes | - | 4.95 Million | -136 Thousand | - | - | - |
| Stock-based compensation | 971 Thousand | 210 Thousand | 200 Thousand | - | - | - |
| Change in working capital | -92 Thousand | 689 Thousand | -31 Thousand | -231 Thousand | 70 Thousand | 28 Thousand |
| Other non-cash items | 8.74 Million | -29 Thousand | -145 Thousand | -9000.00 | -9.00 | -3000.00 |
| Investing Cash Flow | -786 Thousand | -4 Million | -2.5 Million | -2.41 Million | -19 Thousand | - |
| Investments in PPE | -33 Thousand | - | -500 Thousand | -12 Thousand | - | - |
| Acquisitions | - | - | - | -500 Thousand | - | - |
| Investment purchases | -15 Thousand | - | - | - | -19 Thousand | - |
| Sales/Maturities of investments | - | - | 19 Thousand | - | - | - |
| Other Investing Activities | -80 Thousand | -4000.00 | -2.01 Million | -1.9 Million | -19.00 | - |
| Financing Cash Flow | - | - | 11.44 Million | 7.74 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 11.44 Million | 6.99 Million | - | - |
| Other Financing Activities | - | - | 11.44 Thousand | 748 Thousand | - | - |
| Accounts receivables | -73 Thousand | 299.00 | -104.00 | -174.00 | 39.00 | -9000.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5000.00 | 364.00 | 10.00 | -51.00 | 38.00 | 34 Thousand |
| Cash at beginning of period | 5.24 Million | 11.96 Million | 5.67 Million | 1.88 Million | 3.04 Million | 4.28 Million |
| Cash at end of period | 50 Thousand | 5.24 Million | 11.94 Million | 5.67 Million | 1.88 Million | 3.04 Million |
| Capital Expenditure | -33 Thousand | - | -500 Thousand | -12 Thousand | - | - |
| Effect of forex changes on cash | 1000.00 | 33 Thousand | -17 Thousand | - | - | - |
| Net cash flow / Change in cash | -5.19 Million | -6.72 Million | 6.27 Million | 3.79 Million | -1.16 Million | -1.24 Million |
| Free Cash Flow | -4.43 Million | -2.75 Million | -3.15 Million | -1.54 Million | -1.14 Million | -1.24 Million |
| Breakdown | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.2 Million | - | -8.58 Million | -6.91 Million | -1.65 Million | -2.55 Million |
| Depreciation & Amortization | 2000.00 | - | 7000.00 | 5000.00 | 2000.00 | 4000.00 |
| Deferred income taxes | - | - | 4.95 Million | - | - | -136 Thousand |
| Stock-based compensation | 971 Thousand | - | 210 Thousand | - | - | 200 Thousand |
| Change in working capital | -92 Thousand | - | 689 Thousand | 183 Thousand | 506 Thousand | -31 Thousand |
| Other non-cash items | 8.74 Million | - | -29 Thousand | 5.18 Million | -371 Thousand | -145 Thousand |
| Investing Cash Flow | -786 Thousand | - | -4 Million | - | -4 Million | -2.5 Million |
| Investments in PPE | -33 Thousand | - | - | - | - | -500 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -15 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 19 Thousand |
| Other Investing Activities | -80 Thousand | - | -4000.00 | - | -4 Million | -2.01 Million |
| Financing Cash Flow | - | - | - | 86 Thousand | -86 Thousand | 11.44 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 86 Thousand | -86 Thousand | 11.44 Million |
| Other Financing Activities | - | - | - | - | - | 11.44 Thousand |
| Accounts receivables | -73 Thousand | - | 299.00 | 50 Thousand | 249 Thousand | -104.00 |
| Accounts payables | - | - | - | 55 Thousand | -29 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5000.00 | - | 364.00 | 78 Thousand | 286 Thousand | 10.00 |
| Cash at beginning of period | 5.24 Million | 5.24 Million | 11.96 Million | 6.6 Million | 11.96 Million | 5.67 Million |
| Cash at end of period | 50 Thousand | 5.24 Million | 5.24 Million | 5.24 Million | 6.6 Million | 11.94 Million |
| Capital Expenditure | -33 Thousand | - | - | - | - | -500 Thousand |
| Effect of forex changes on cash | 1000.00 | - | 33 Thousand | - | - | -17 Thousand |
| Net cash flow / Change in cash | -5.19 Million | - | -6.72 Million | -1.36 Million | -5.35 Million | 6.27 Million |
| Free Cash Flow | -4.43 Million | - | -2.75 Million | -1.44 Million | -1.3 Million | -3.15 Million |
EQGPF
0RWM
1214
FTAI
UNISON
TOBII